Fig. 1
From: Identification and validation of platinum resistance signature in gastric cancer
Flowchart of the study. 375 stomach adenocarcinoma (STAD) and 32 normal tissue samples were included in this study. Drug resistance model was developed and validated. Further, GSEA, GSVA, clinical prognosis and immune activity analysis of drug resistance score were analyzed. Resistant cells, PDO and PDX were then used to validate the efficacy of drug resistance model